Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Capsaicin | 9 | 2023 | 23 | 2.770 |
Why?
|
| TRPV Cation Channels | 7 | 2022 | 24 | 2.150 |
Why?
|
| Neuromuscular Junction | 5 | 2019 | 33 | 1.870 |
Why?
|
| Guanylate Cyclase | 8 | 2013 | 17 | 1.330 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 6 | 2013 | 58 | 1.200 |
Why?
|
| Obesity | 5 | 2023 | 965 | 1.120 |
Why?
|
| Thermogenesis | 4 | 2021 | 20 | 1.100 |
Why?
|
| Adipose Tissue, White | 3 | 2021 | 13 | 0.950 |
Why?
|
| Heme | 3 | 2011 | 69 | 0.890 |
Why?
|
| Diabetic Neuropathies | 1 | 2022 | 11 | 0.880 |
Why?
|
| Diterpenes | 1 | 2022 | 83 | 0.840 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2022 | 87 | 0.810 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 115 | 0.760 |
Why?
|
| Adipose Tissue, Brown | 2 | 2021 | 39 | 0.750 |
Why?
|
| Metabolism | 1 | 2019 | 9 | 0.710 |
Why?
|
| Nitric Oxide | 5 | 2012 | 287 | 0.660 |
Why?
|
| Animals | 23 | 2022 | 14307 | 0.640 |
Why?
|
| Lipolysis | 1 | 2017 | 18 | 0.620 |
Why?
|
| Spectrophotometry | 1 | 2017 | 71 | 0.620 |
Why?
|
| Energy Metabolism | 1 | 2018 | 160 | 0.620 |
Why?
|
| Glycerol | 1 | 2017 | 29 | 0.620 |
Why?
|
| Mice | 13 | 2021 | 5668 | 0.600 |
Why?
|
| Adipose Tissue | 2 | 2018 | 167 | 0.600 |
Why?
|
| Cholesterol | 1 | 2017 | 194 | 0.570 |
Why?
|
| Feeding Behavior | 2 | 2019 | 418 | 0.560 |
Why?
|
| Neuromuscular Agents | 1 | 2014 | 4 | 0.500 |
Why?
|
| Evoked Potentials, Motor | 1 | 2014 | 10 | 0.500 |
Why?
|
| TRPM Cation Channels | 3 | 2020 | 35 | 0.440 |
Why?
|
| Recombinant Proteins | 2 | 2013 | 485 | 0.430 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 2013 | 127 | 0.420 |
Why?
|
| Receptors, Androgen | 3 | 2020 | 122 | 0.420 |
Why?
|
| Testosterone | 3 | 2020 | 181 | 0.420 |
Why?
|
| Aspartic Acid | 1 | 2011 | 46 | 0.400 |
Why?
|
| Acetylcholine | 4 | 2014 | 68 | 0.380 |
Why?
|
| Cyclophilin A | 3 | 2014 | 14 | 0.360 |
Why?
|
| Rats | 10 | 2022 | 3261 | 0.360 |
Why?
|
| Mice, Inbred C57BL | 6 | 2017 | 1530 | 0.360 |
Why?
|
| Mice, Knockout | 4 | 2019 | 897 | 0.310 |
Why?
|
| Pain | 2 | 2022 | 249 | 0.300 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 1300 | 0.280 |
Why?
|
| Enzyme Activation | 5 | 2013 | 423 | 0.260 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 968 | 0.260 |
Why?
|
| COS Cells | 4 | 2013 | 62 | 0.250 |
Why?
|
| Angiotensin II | 3 | 2013 | 92 | 0.240 |
Why?
|
| Protein Structure, Tertiary | 4 | 2011 | 383 | 0.230 |
Why?
|
| Swine, Miniature | 1 | 2022 | 8 | 0.220 |
Why?
|
| Analgesics | 1 | 2022 | 56 | 0.210 |
Why?
|
| Swine | 1 | 2022 | 182 | 0.210 |
Why?
|
| Type C Phospholipases | 1 | 2020 | 19 | 0.190 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 161 | 0.190 |
Why?
|
| Male | 9 | 2021 | 18870 | 0.190 |
Why?
|
| Mutation | 4 | 2013 | 1023 | 0.190 |
Why?
|
| Sexual Behavior, Animal | 1 | 2020 | 51 | 0.190 |
Why?
|
| Cells, Cultured | 5 | 2016 | 1442 | 0.190 |
Why?
|
| Myocytes, Smooth Muscle | 4 | 2013 | 84 | 0.180 |
Why?
|
| Heart Function Tests | 1 | 2019 | 12 | 0.180 |
Why?
|
| Organ Size | 1 | 2019 | 148 | 0.170 |
Why?
|
| Capsicum | 1 | 2018 | 5 | 0.170 |
Why?
|
| PPAR gamma | 1 | 2018 | 49 | 0.170 |
Why?
|
| Behavior, Animal | 1 | 2020 | 304 | 0.160 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 120 | 0.160 |
Why?
|
| Signal Transduction | 5 | 2020 | 1802 | 0.160 |
Why?
|
| Diaphragm | 1 | 2017 | 10 | 0.160 |
Why?
|
| Body Weight | 1 | 2019 | 404 | 0.150 |
Why?
|
| Polyglycolic Acid | 1 | 2017 | 35 | 0.150 |
Why?
|
| Endocytosis | 1 | 2017 | 104 | 0.150 |
Why?
|
| Lactic Acid | 1 | 2017 | 87 | 0.140 |
Why?
|
| Animals, Newborn | 1 | 2017 | 323 | 0.140 |
Why?
|
| Time Factors | 4 | 2014 | 1681 | 0.140 |
Why?
|
| Protein Interaction Mapping | 2 | 2013 | 57 | 0.140 |
Why?
|
| Cytokines | 1 | 2019 | 569 | 0.140 |
Why?
|
| Vasodilation | 2 | 2012 | 65 | 0.130 |
Why?
|
| 4-Aminopyridine | 1 | 2014 | 7 | 0.130 |
Why?
|
| Ionomycin | 1 | 2014 | 9 | 0.130 |
Why?
|
| Potassium Channel Blockers | 1 | 2014 | 30 | 0.120 |
Why?
|
| Reflex | 1 | 2014 | 31 | 0.120 |
Why?
|
| Electromyography | 1 | 2014 | 49 | 0.120 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2014 | 3 | 0.120 |
Why?
|
| Acetylcholinesterase | 1 | 2014 | 53 | 0.120 |
Why?
|
| Mesenteric Arteries | 1 | 2014 | 18 | 0.120 |
Why?
|
| Electric Stimulation | 1 | 2014 | 177 | 0.120 |
Why?
|
| Caveolae | 1 | 2013 | 8 | 0.120 |
Why?
|
| Half-Life | 1 | 2013 | 52 | 0.120 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2013 | 12 | 0.120 |
Why?
|
| Protein Subunits | 2 | 2011 | 85 | 0.120 |
Why?
|
| Muscles | 1 | 2013 | 64 | 0.120 |
Why?
|
| Neuroblastoma | 1 | 2014 | 128 | 0.120 |
Why?
|
| Thrombosis | 1 | 2014 | 61 | 0.120 |
Why?
|
| Blood Platelets | 1 | 2014 | 74 | 0.120 |
Why?
|
| Aorta | 2 | 2011 | 161 | 0.110 |
Why?
|
| Blotting, Western | 2 | 2013 | 834 | 0.110 |
Why?
|
| Models, Molecular | 3 | 2011 | 751 | 0.110 |
Why?
|
| Carbon Monoxide | 1 | 2011 | 30 | 0.100 |
Why?
|
| Catalytic Domain | 1 | 2011 | 97 | 0.100 |
Why?
|
| Indazoles | 1 | 2011 | 9 | 0.100 |
Why?
|
| Alanine | 1 | 2011 | 28 | 0.100 |
Why?
|
| Protein Binding | 4 | 2014 | 913 | 0.100 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 2128 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2011 | 249 | 0.100 |
Why?
|
| Reactive Oxygen Species | 4 | 2014 | 416 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 168 | 0.100 |
Why?
|
| Nostoc | 1 | 2010 | 1 | 0.100 |
Why?
|
| Benzoates | 1 | 2010 | 15 | 0.100 |
Why?
|
| Molecular Mimicry | 1 | 2010 | 16 | 0.090 |
Why?
|
| Immunoprecipitation | 3 | 2014 | 126 | 0.090 |
Why?
|
| Humans | 9 | 2023 | 34853 | 0.080 |
Why?
|
| Protein Kinases | 1 | 2007 | 91 | 0.080 |
Why?
|
| Nitrogen | 1 | 2007 | 63 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2012 | 874 | 0.070 |
Why?
|
| Acetylation | 2 | 2018 | 94 | 0.070 |
Why?
|
| Hypertension | 1 | 2012 | 770 | 0.070 |
Why?
|
| Female | 2 | 2020 | 19873 | 0.060 |
Why?
|
| Polymers | 1 | 2023 | 117 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 859 | 0.050 |
Why?
|
| Cyclic GMP | 2 | 2012 | 44 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2023 | 182 | 0.050 |
Why?
|
| Phosphatidylinositols | 1 | 2020 | 12 | 0.050 |
Why?
|
| Inflammation | 2 | 2017 | 577 | 0.050 |
Why?
|
| Kainic Acid | 1 | 2020 | 47 | 0.050 |
Why?
|
| Ventral Tegmental Area | 1 | 2020 | 36 | 0.050 |
Why?
|
| Aggression | 1 | 2020 | 75 | 0.050 |
Why?
|
| Cell Line | 2 | 2014 | 1289 | 0.050 |
Why?
|
| Cysteine | 2 | 2012 | 88 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 984 | 0.040 |
Why?
|
| Social Behavior | 1 | 2020 | 124 | 0.040 |
Why?
|
| 3T3-L1 Cells | 1 | 2018 | 14 | 0.040 |
Why?
|
| Transfection | 2 | 2012 | 496 | 0.040 |
Why?
|
| Adipogenesis | 1 | 2018 | 12 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2018 | 24 | 0.040 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2018 | 22 | 0.040 |
Why?
|
| Mutagenesis | 2 | 2010 | 87 | 0.040 |
Why?
|
| Epididymis | 1 | 2018 | 28 | 0.040 |
Why?
|
| Sirtuin 1 | 1 | 2018 | 32 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2020 | 213 | 0.040 |
Why?
|
| Ion Channel Gating | 1 | 2018 | 81 | 0.040 |
Why?
|
| Crystallography, X-Ray | 2 | 2010 | 237 | 0.040 |
Why?
|
| PPAR alpha | 1 | 2018 | 42 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 109 | 0.040 |
Why?
|
| Weight Loss | 1 | 2018 | 124 | 0.040 |
Why?
|
| Endothelial Cells | 2 | 2013 | 296 | 0.040 |
Why?
|
| Fluorescein | 1 | 2017 | 15 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2017 | 57 | 0.040 |
Why?
|
| Solubility | 1 | 2017 | 115 | 0.040 |
Why?
|
| Surface Properties | 1 | 2017 | 121 | 0.040 |
Why?
|
| Particle Size | 1 | 2017 | 200 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 173 | 0.040 |
Why?
|
| Drug Carriers | 1 | 2017 | 121 | 0.030 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2014 | 1 | 0.030 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2014 | 7 | 0.030 |
Why?
|
| Phrenic Nerve | 1 | 2014 | 17 | 0.030 |
Why?
|
| Exocytosis | 1 | 2014 | 45 | 0.030 |
Why?
|
| Platelet Aggregation | 1 | 2014 | 17 | 0.030 |
Why?
|
| Fibrinogen | 1 | 2014 | 23 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2018 | 1152 | 0.030 |
Why?
|
| Thrombin | 1 | 2014 | 24 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2013 | 27 | 0.030 |
Why?
|
| Lipid Bilayers | 1 | 2014 | 66 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 818 | 0.030 |
Why?
|
| Chlorides | 1 | 2014 | 52 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2014 | 46 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2013 | 53 | 0.030 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2013 | 23 | 0.030 |
Why?
|
| Ferric Compounds | 1 | 2014 | 49 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2014 | 98 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 40 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 445 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 185 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2013 | 97 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2014 | 209 | 0.030 |
Why?
|
| Nitrosation | 1 | 2012 | 5 | 0.030 |
Why?
|
| Arterioles | 1 | 2012 | 18 | 0.030 |
Why?
|
| Nitric Oxide Donors | 1 | 2012 | 18 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 240 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 2012 | 32 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 286 | 0.030 |
Why?
|
| Protein Transport | 1 | 2013 | 286 | 0.030 |
Why?
|
| Hela Cells | 1 | 2013 | 344 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 407 | 0.030 |
Why?
|
| Calcium | 1 | 2014 | 445 | 0.030 |
Why?
|
| Gene Expression | 1 | 2014 | 639 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 396 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 608 | 0.030 |
Why?
|
| Models, Animal | 1 | 2011 | 131 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2011 | 202 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 162 | 0.020 |
Why?
|
| Enzyme Activators | 1 | 2010 | 10 | 0.020 |
Why?
|
| Peptides | 1 | 2013 | 308 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2013 | 878 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2010 | 172 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2010 | 376 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2012 | 613 | 0.020 |
Why?
|
| Haplorhini | 1 | 2007 | 21 | 0.020 |
Why?
|
| S-Nitrosothiols | 1 | 2007 | 3 | 0.020 |
Why?
|
| Veins | 1 | 2007 | 7 | 0.020 |
Why?
|
| Dimerization | 1 | 2007 | 102 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2007 | 106 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 1534 | 0.020 |
Why?
|
| Cell Separation | 1 | 2007 | 91 | 0.020 |
Why?
|
| Genome | 1 | 2007 | 117 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 157 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2007 | 298 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 1124 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 1490 | 0.020 |
Why?
|